arrow
返回
T

Taroh Satoh

Graduate School of Medicine

55H指数
527论文数
2.5W被引数
收录论文 117
发表时间
Targeting fibroblast activation protein in solid tumors via LNP-mediated CAR-mRNA delivery promotes durable regression in murine models通过LNP介导的CAR-mRNA递送靶向实体瘤中的成纤维细胞活化蛋白,在啮齿动物模型中促进持久的肿瘤消退。
err2025-12-10
err0
errOAAI
errSikun Meng; Tomoaki Hara; Tetsuya Sato; Shotaro Tatekawa; Yasuko Arao; Yoshiko Saito; Toshiro Hirai; Daisuke Motooka; Sarah Rennie; Taroh Satoh; Kazuhiko Ogawa; Yutaka Miura; Masaki Mori; Yuichiro Doki; Hidetoshi Eguchi; Hideshi Ishii
err分享
err收藏
Clinical significance of comprehensive genomic profiling in unresectable or recurrent gastrointestinal stromal tumors: a multicenter retrospective cohort study不可切除或复发性胃肠道间质瘤综合基因组分析的临床意义:一项多中心回顾性队列研究
err2025-11-21
err0
PREAI
errKota Kawabata; Tsuyoshi Takahashi; Hisashi Hara; Yukinori Kurokawa; Kazuyoshi Yamamoto; Takuro Saito; Yusuke Akamaru; Masaaki Motoori; Toshirou Nishida; Seiichi Hirota; Taroh Satoh; Hidetoshi Eguchi; Yuichiro Doki
err分享
err收藏
ASTRON (OGSG 2401) study protocol: Ferric carboxymaltose for iron deficiency anemia in gastrointestinal cancerASTRON (OGSG 2401)研究方案:羧基麦芽糖铁用于胃肠癌缺铁性贫血
err2025-10-21
err0
PREAI
errHiroki Yukami; Toshifumi Yamaguchi; Shunji Endo; Shogen Boku; Yukinori Kurokawa; Toshimasa Tsujinaka; Toshio Shimokawa; Taroh Satoh
err分享
err收藏
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)一项关于厄洛替尼用于BRAF V600E突变型转移性结直肠癌的多中心II期研究:BRAVERY研究(EPOC1701)
err2025-10-09
err0
errOAAI
errT. Masuishi; H. Taniguchi; D. Kotani; H. Bando; Y. Komatsu; E. Shinozaki; Y. Sunakawa; T. Satoh; T. Nishina; T. Esaki; M. Wakabayashi; S. Nomura; K. Takahashi; H. Ono; N. Hirano; N. Fujishiro; N. Fuse; A. Sato; Y. Sakamoto; N. Kuramoto; I. Miki; H. Ichiki; Y. Nakamura; G. Sharma; S. Skrzypczak; E. Schultz; C. Kingsford; A. Ohtsu; T. Yoshino
err分享
err收藏
ASO Visual Abstract: Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 MutationsASO视觉摘要:SOAT1抑制剂对TP53突变型胰腺癌的疗效
err2025-07-29
err0
PREAI
errRyosuke Maki; Yoshifumi Iwagami; Shogo Kobayashi; Kazuki Sasaki; Daisaku Yamada; Yoshito Tomimaru; Daisuke Sakai; Takehiro Noda; Tadafumi Asaoka; Hidenori Takahashi; Taroh Satoh; Junzo Shimizu; Yuichiro Doki; Hidetoshi Eguchi
err分享
err收藏
Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701)
err2024-11-09
err0
PREAI
errKimura, Yutaka; Sugimoto, Naotoshi; Endo, Shunji; Kawabata, Ryohei; Matsuyama, Jin; Takeno, Atsushi; Nakamura, Masato; Takeshita, Hiroki; Satake, Hironaga; Tamura, Shigeyuki; Sakai, Daisuke; Kawakami, Hisato; Kurokawa, Yukinori; Shimokawa, Toshio; Satoh, Taroh
err分享
err收藏
Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: A FRESCO-2 subgroup analysis by agefruquintinib在难治性转移性结直肠癌中的有效性和安全性:一项基于年龄的FRESCO-2亚组分析
err2024-09-01
err0
PREAI
errElez Fernandez, M. E.; Dasari, N. A.; Lonardi, S.; Eng, C.; Garcia-Carbonero, R.; Yoshino, T.; Sobrero, A.; Yao, J. C.; Garcia Alfonso, P.; Kocsis, J.; Cubillo Gracian, A.; Sartore Bianchi, A.; Satoh, T.; Randrian, V.; Cremolini, C.; Yang, Z.; Schelman, W.; Zhu, H.; Chen, L.; Tabernero, J.
err分享
err收藏
Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer循环肿瘤DNA中BRCA和ATM突变状态在晚期胰腺癌治疗选择中的临床应用
err2024-08-28
err0
PREAI
errSudo, Kentaro; Nakamura, Yoshiaki; Ueno, Makoto; Furukawa, Masayuki; Mizuno, Nobumasa; Kawamoto, Yasuyuki; Okano, Naohiro; Umemoto, Kumiko; Asagi, Akinori; Ozaka, Masato; Ohtsubo, Koushiro; Shimizu, Satoshi; Matsuhashi, Nobuhisa; Itoh, Shinji; Matsumoto, Toshihiko; Satoh, Taroh; Okuyama, Hiroyuki; Goto, Masahiro; Hasegawa, Hiroko; Yamamoto, Yoshiyuki; Odegaard, Justin I.; Bando, Hideaki; Yoshino, Takayuki; Ikeda, Masafumi; Morizane, Chigusa
err分享
err收藏
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy与NeoRAS野生型转移性结直肠癌相关的临床特征scrum-japan GOZILA子研究
err2024-07-13
err1
errOAAI
errOsumi, Hiroki; Shinozaki, Eiji; Nakamura, Yoshiaki; Esaki, Taito; Yasui, Hisateru; Taniguchi, Hiroya; Satake, Hironaga; Sunakawa, Yu; Komatsu, Yoshito; Kagawa, Yoshinori; Denda, Tadamichi; Shiozawa, Manabu; Satoh, Taroh; Nishina, Tomohiro; Goto, Masahiro; Takahashi, Naoki; Kato, Takeshi; Bando, Hideaki; Yamaguchi, Kensei; Yoshino, Takayuki
err分享
err收藏
Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications
err2024-06-17
err1
errOAAI
errSato, Hiromichi; Meng, Sikun; Hara, Tomoaki; Tsuji, Yoshiko; Arao, Yasuko; Sasaki, Kazuki; Kobayashi, Shogo; di Luccio, Eric; Hirotsu, Takaaki; Satoh, Taroh; Doki, Yuichiro; Eguchi, Hidetoshi; Ishii, Hideshi
err分享
err收藏
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study
err2024-06-01
err0
errOAAI
errYuki, Satoshi; Yamazaki, Kentaro; Sunakawa, Yu; Taniguchi, Hiroya; Bando, Hideaki; Shiozawa, Manabu; Nishina, Tomohiro; Yasui, Hisateru; Kanazawa, Akiyoshi; Ando, Koji; Horita, Yosuke; Goto, Masahiro; Okano, Naohiro; Moriwaki, Toshikazu; Satoh, Taroh; Tsuji, Akihito; Yamashita, Kaname; Asano, Chiharu; Abe, Yukiko; Nomura, Shogo; Yoshino, Takayuki
err分享
err收藏
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
err2024-06-01
err1
errOAAI
errKotani, Daisuke; Takashima, Atsuo; Kato, Takeshi; Satoh, Taroh; Masuishi, Toshiki; Komatsu, Yoshito; Shiozawa, Manabu; Esaki, Taito; Izawa, Naoki; Takeuchi, Shinji; Bando, Hideaki; Iwasa, Satoru; Hasegawa, Hiroko; Yamaguchi, Toshifumi; Taniguchi, Hiroya; Ushida, Yasunori; Oizaki, Toshiya; Inoue, Chiaki; Yoshino, Takayuki
err分享
err收藏
Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B
err2024-04-17
err0
errOAAI
errKawamoto, Yasuyuki; Morizane, Chigusa; Komatsu, Yoshito; Kondo, Shunsuke; Ueno, Makoto; Kobayashi, Satoshi; Furukawa, Masayuki; Lee, Lingaku; Satoh, Taroh; Sakai, Daisuke; Ikeda, Masafumi; Imaoka, Hiroshi; Miura, Arisa; Hatanaka, Yutaka; Yokota, Isao; Nakamura, Yoshiaki; Yoshino, Takayuki
err分享
err收藏
Efficacy and safety of fruquintinib (F) plus best supportive care (BSC) vs placebo (P) plus BSC in refractory metastatic colorectal cancer (mCRC): Asian vs non-Asian outcomes in FRESCO-2
err2023-11-01
err0
PREAI
errKotani, D.; Yoshino, T.; Paulson, A. S.; Masuishi, T.; Hochster, H.; Krauss, J.; Sunakawa, Y.; Takashima, A.; Yamazaki, K.; Kawakami, H.; Nishina, T.; Komatsu, Y.; Esaki, T.; Eng, C.; Dasari, N. A.; Yu, Z.; Chen, L.; Yang, T.; Schelman, W.; Satoh, T.
err分享
err收藏
Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with solid tumors harboring specific HER2-activating mutations (HER2m): Primary results from the international phase II DESTINY-PanTumor01 (DPT-01) study
err2023-10-01
err15
PREAI
errLi, B. T.; Meric-Bernstam, F.; Bardia, A.; Naito, Y.; Siena, S.; Aftimos, P. G.; Anderson, I.; Curigliano, G.; De Miguel Luken, M. J.; Kalra, M.; Oh, D-Y.; Park, J. O.; Postel-Vinay, S.; Rha, S. Y.; Satoh, T.; Spanggaard, I.; Michelini, F.; Smith, A.; Machado, K. Kalil; Saura Manich, C.
err分享
err收藏
The primary results of an intergroup phase III randomized controlled trial comparing ramucirumab plus irinotecan with irinotecan in the third or later line treatment beyond progression after ramucirumab for advanced gastric cancer (RINDBeRG trial)
err2023-10-01
err3
errOAAI
errKadowaki, S.; Sakai, D.; Kawabata, R.; Hara, H.; Yasui, H.; Takahashi, M.; Hirao, M.; Imai, H.; Minashi, K.; Kawakami, T.; Satake, H.; Matsuyama, J.; Sakamoto, Y.; Sawada, K.; Kataoka, M.; Kawakami, H.; Shimokawa, T.; Boku, N.; Satoh, T.
err分享
err收藏
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)TP53基因的突变谱与晚期胃癌的nivolumab治疗效果相关 (TP53MUT研究)
err2023-08-02
err4
PREAI
errAndo, Koji; Nakamura, Yoshiaki; Kitao, Hiroyuki; Shimokawa, Mototsugu; Kotani, Daisuke; Bando, Hideaki; Nishina, Tomohiro; Yamada, Takanobu; Yuki, Satoshi; Narita, Yukiya; Hara, Hiroki; Ohta, Takashi; Esaki, Taito; Hamamoto, Yasuo; Kato, Ken; Yamamoto, Yoshiyuki; Minashi, Keiko; Ohtsubo, Koushiro; Izawa, Naoki; Kawakami, Hisato; Kato, Takeshi; Satoh, Taroh; Okano, Naohiro; Tsuji, Akihito; Yamazaki, Kentaro; Yoshino, Takayuki; Maehara, Yoshihiko; Oki, Eiji
err分享
err收藏
Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection微卫星不稳定性对根治性切除术后接受S-1辅助单药治疗的II期胃癌患者生存的影响
err2023-07-04
err0
errOAAI
errSato, Chihiro; Kawakami, Hisato; Tanaka, Ryo; Satake, Hironaga; Inoue, Kentaro; Kimura, Yutaka; Fujita, Junya; Kawabata, Ryohei; Chiba, Yasutaka; Satoh, Taroh; Nakagawa, Kazuhiko
err分享
err收藏
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyFruquintinib与安慰剂在难治性转移性结直肠癌患者中的比较 (FRESCO-2): 一项国际,多中心,随机,双盲,3期研究
errLANCET
IF88.5
err2023-07-01
err101
PREAI
errDasari, Arvind; Lonardi, Sara; Garcia-Carbonero, Rocio; Elez, Elena; Yoshino, Takayuki; Sobrero, Alberto; Yao, James; Garcia-Alfonso, Pilar; Kocsis, Judit; Gracian, Antonio Cubillo; Sartore-Bianchi, Andrea; Satoh, Taroh; Randrian, Violaine; Tomasek, Jiri; Chong, Geoff; Paulson, Andrew Scott; Masuishi, Toshiki; Jones, Jeremy; Csoszi, Tibor; Cremolini, Chiara; Ghiringhelli, Francois; Shergill, Ardaman; Hochster, Howard S.; Krauss, John; Bassam, Ali; Ducreux, Michel; Elme, Anneli; Faugeras, Laurence; Kasper, Stefan; Van Cutsem, Eric; Arnold, Dirk; Nanda, Shivani; Yang, Zhao; Schelman, William R.; Kania, Marek; Tabernero, Josep; Eng, Cathy
err分享
err收藏